✦ LIBER ✦

Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study

✍ Scribed by Arvind Chopra; Manjit Saluja; Girish Tillu; Anuradha Venugopalan; Gumdal Narsimulu; Rohini Handa; Lata Bichile; Ashwinikumar Raut; Sanjeev Sarmukaddam; Bhushan Patwardhan

Publisher: Springer
Year: 2011
Tongue: English
Weight: 260 KB
Volume: 31
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-011-1809-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alpha-linolenic acid in the treatment of

Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed

✍ D. C. E. Nordström; C. Friman; Y. T. Konttinen; V. E. A. Honkanen; Y. Nasu; E. A 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 495 KB

In rheumatoid arthritis various pro-inflammatory metabolites of arachidonic acid (AA), such as leukotriene B4 (LTB4) and prostaglandin E2 (PGE2), contribute to tissue destruction and pain. In contrast to AA, which is an omega-6 fatty acid, the omega-3 fatty acids, after having been liberated from th

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Effect of folic or folinic acid suppleme

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight–week, multicenter, randomized, double-blind, placebo-controlled study

✍ Annelies E. Van Ede; Roland F. J. M. Laan; Maarten J. Rood; Tom W. J. Huizinga; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

LY2439821, a humanized anti–interleukin-

LY2439821, a humanized anti–interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

✍ M. C. Genovese; F. Van den Bosch; S. A. Roberson; S. Bojin; I. M. Biagini; Peter 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views